Literature DB >> 18945838

Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system.

Anandi Martin1, Andrea von Groll, Krista Fissette, Juan Carlos Palomino, Francis Varaine, Françoise Portaels.   

Abstract

The objective of this study was to evaluate the manual mycobacterium growth indicator tube (MGIT) system for the testing of Mycobacterium tuberculosis susceptibility to second-line drugs compared to the proportion method. One hundred eighty-eight M. tuberculosis isolates were tested for susceptibility to ofloxacin, kanamycin, ethionamide, and capreomycin by the manual MGIT, and results were compared to those obtained with the proportion method on 7H11 agar, considered a reference method. Results for ofloxacin and capreomycin were excellent, with 100% accuracy, and a result of 99.4% accuracy was achieved for kanamycin. For ethionamide, accuracy was lower, with a result of 86.7% compared to that of the proportion method. We proposed the following critical concentrations for the drugs: for ofloxacin, 2.0 microg/ml; for kanamycin, 2.5 microg/ml; for ethionamide, 5 microg/ml; and for capreomycin, 2.5 microg/ml. The time required to obtain results was an average of 8 days by the manual MGIT and 3 weeks by the reference method. Our results show that the manual MGIT is an accurate method for the rapid susceptibility testing of M. tuberculosis to second-line drugs. There is no need for a machine when using the manual MGIT, and results can be read with a simple UV lamp or with a semiquantitative reader, which considerably reduces the cost of the method.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945838      PMCID: PMC2593252          DOI: 10.1128/JCM.01171-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method.

Authors:  I Bastian; L Rigouts; J C Palomino; F Portaels
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Drug resistance in tuberculosis.

Authors:  D A Mitchison
Journal:  Eur Respir J       Date:  2005-02       Impact factor: 16.671

3.  Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials.

Authors:  Sabine Rüsch-Gerdes; Gaby E Pfyffer; Manuel Casal; Maureen Chadwick; Salman Siddiqi
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

4.  Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.

Authors:  Annika Krüüner; Malcolm D Yates; Francis A Drobniewski
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

5.  In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.

Authors:  R Pracharktam; K Angkananukool; A Vibhagool
Journal:  J Med Assoc Thai       Date:  2001-09

6.  Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  F Ardito; B Posteraro; M Sanguinetti; S Zanetti; G Fadda
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 7.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

8.  Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis.

Authors:  Pascale Bemer; Frantiska Palicova; Sabine Rüsch-Gerdes; Henri B Drugeon; Gaby E Pfyffer
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

9.  Evaluation of the resazurin microtiter assay for rapid detection of ofloxacin resistance in M. tuberculosis.

Authors:  A N Umubyeyi; A Martin; G Zissis; M Struelens; E Karita; F Portaels
Journal:  Int J Tuberc Lung Dis       Date:  2006-07       Impact factor: 2.373

10.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

View more
  5 in total

1.  Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.

Authors:  S-Y Grace Lin; Edward Desmond; Donald Bonato; Wendy Gross; Salman Siddiqi
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

2.  Performance of Genotype MTBDRsl V2.0 over the Genotype MTBDRsl V1 for detection of second line drug resistance: An Indian perspective.

Authors:  Syed Beenish Rufai; Kulsum Umay; Praveen Kumar Singh; Sarman Singh
Journal:  PLoS One       Date:  2020-03-04       Impact factor: 3.240

3.  Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa.

Authors:  Halima M Said; Marleen M Kock; Nazir A Ismail; Kamaldeen Baba; Shaheed V Omar; Ayman G Osman; Anwar A Hoosen; Marthie M Ehlers
Journal:  BMC Infect Dis       Date:  2012-12-22       Impact factor: 3.090

4.  Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.

Authors:  Chhavi Porwal; Amit Kaushik; Nayani Makkar; Jayant N Banavaliker; Mahmud Hanif; Rupak Singla; Anuj K Bhatnagar; Digambar Behera; Jitendra Nath Pande; Urvashi B Singh
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

5.  Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe.

Authors:  Tichaona Sagonda; Lucy Mupfumi; Rumbidzai Manzou; Beauty Makamure; Mqondisi Tshabalala; Lovemore Gwanzura; Peter Mason; Reggie Mutetwa
Journal:  Tuberc Res Treat       Date:  2014-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.